Hostname: page-component-77c89778f8-n9wrp Total loading time: 0 Render date: 2024-07-18T22:30:20.388Z Has data issue: false hasContentIssue false

Infections in Burned Patients

Published online by Cambridge University Press:  02 January 2015

C. Glen Mayhall*
Affiliation:
Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia
Ronald E. Polk
Affiliation:
Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia
Boyd W. Haynes
Affiliation:
Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia
*
Hospital Epidemiology Unit, Division of Infectious Diseases, Medical College of Virginia, Box 49, MCV Station, Richmond, VA 23298

Abstract

Prevention and treatment of burn wound infection requires knowledge of the epidemiology of such infections. Prevention of infection rests on removal of reservoirs or sources of microorganisms from the burn patient's environment and interruption of transfer of microorganisms to the surface of the wound. When prevention fails and burn wound infection develops, successful therapy may depend on an understanding of the epidemiology of the burn wound during therapy. Contrary to the oft stated concept that antibiotics penetrate the avascular burn wound poorly, our study demonstrated that gentamicin and tobramycin achieved therapeutic concentrations in burn wound tissue. As in other types of infections, susceptible microorganisms were eradicated and resistant microorganisms persisted. Of most importance was the observation that resistant microorganisms may repopulate the wound within four days of starting therapy. It would appear that failure of therapy is not due to failure of antibiotics to penetrate the burn wound but rather to rapid development of superinfection during therapy.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1983

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Mayhall, CG: Infections in burn patients, in Wenzel, RP (ed): Handbook of Hospital Acquired Infections. Boca Raton, CRC Press, Inc, 1981, p 317.Google Scholar
2.Marvin, JA, Heck, EL, Loebl, EC, et al: Usefulness of blood cultures in confirming septic complications in burn patients: Evaluation of a new culture method. J Trauma 1975;15:657662.CrossRefGoogle ScholarPubMed
3.Lowbury, EJL, Fox, J: The epidemiology of infection with Pseudomonas pyocyanea in a burn unit. J Hyg 1954;52:403416.CrossRefGoogle Scholar
4.Shooter, RA, Walker, KA, Williams, VR, et al: Fecal carriage of Pseudomonas aeruginosa in hospital patients. Possible spread from patient to patient. Lancet 1966;2:13311334.CrossRefGoogle ScholarPubMed
5.Shooter, RA, Cooke, EM, Haya, H, et al: Food and medicaments as possible sources of hospital strains of Pseudomonas aeruginosa. Lancet 1969;1:12271229.CrossRefGoogle ScholarPubMed
6.Shooter, RA, Faiers, MC, Cooke, EM, et al: Isolation of Escherichia coli, and Pseudomonas aeruginosa, and Klebsiella from food in hospitals, canteens, and schools. Lancet 1971;2:390392.CrossRefGoogle ScholarPubMed
7.Kominos, SD, Copeland, CE, Grosiak, B, et al: Introduction of Pseudomonas aeruginosa into a hospital via vegetables. Appl Environ Microbiol 1972;24:567570.CrossRefGoogle ScholarPubMed
8.Kominos, SD, Copeland, CE, Delenko, CA: Pseudomonas aeruginosa from vegetables, salads, and other foods served to patients with burns, in Young, VM (ed): Pseudomonas aeruginosa: Ecological Aspects and Patient Colonization. New York, Raven Press, 1977, p 66.Google Scholar
9.Shulman, JA, Terry, PM, Hough, CE: Colonization with gentamicin-resistant Pseudomonas aeruginosa, pyocine Type 5, in a burn unit. J Infect Dis 1971; 124 (suppl):S18S23.CrossRefGoogle Scholar
10.MacMillan, BG, Edmonds, P, Hummel, RP, et al: Epidemiology of Pseudomonas in a burn intensive care unit. J Trauma 1973;13:627638.CrossRefGoogle Scholar
11.Mayhall, CG, Lamb, VA, Gayle, WE Jr, et al: Enterobacter cloacae septicemia in a burn center. Epidemiology and control of an outbreak. J Infect Dis 1979;139:166171.CrossRefGoogle Scholar
12.Wormald, PJ: The effect of a changed environment on bacterial colonization rates in an established burns centre. J Hyg 1970;68:633645.Google Scholar
13.Stone, HH, Kolb, LD: The evolution and spread of gentamicin-resistant Pseudomonas. J Trauma 1971;11:586589.CrossRefGoogle Scholar
14.Holder, IA: Epidemiology of Pseudomonas aeruginosa in a burns hospital, in Young, VM (ed): Pseudomonas aeruginosa: Ecological Aspects and Patient Colonization. New York, Raven Press, 1977, p 86.Google Scholar
15.Ransjö, U: Isolation care of infection-prone burn patients. Scand J Infect Dis 1978; 11(suppl):146.CrossRefGoogle Scholar
16.Cason, JS, Jackson, DM, Lowbury, EJL, et al: Antiseptic and aseptic prophylaxis for burns: Use of silver nitrate and of isolators. Br Med J 1966;2:12881294.CrossRefGoogle ScholarPubMed
17.Lowbury, EJL, Babb, JR, Ford, PM: Protective isolation in a burns unit: The use of plastic isolators and air curtains. J Hyg Camb 1971;69:529546.Google Scholar
18.Hambraeus, A: Dispersal and transfer of Staphylococcus aureus in an isolation ward for burned patients. J Hyg Camb 1973;71:787797.CrossRefGoogle Scholar
19.Hambraeus, A, Laurell, G: Infections in a burns unit. An attempt to study the airborne transfer of bacteria, in Staphylococci and Staphylococcal Infections. Warsaw, Polish Medical Publishers, 1973, p 467.Google Scholar
20.Moncrief, JA, Lindberg, RB, Switzer, WE, et al: Use of topical antibacterial therapy in the treatment of the burn-wound. Arch Surg 1966;92:558565.CrossRefGoogle ScholarPubMed
21.McHugh, GL, Moellering, RC, Hopkins, CC, et al: Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin. A new threat in burn units? Lancet 1975;1:235240.CrossRefGoogle Scholar
22.Wenzel, RP, Hunting, KJ, Osterman, CA, et al: Providencia stuartii, a hospital pathogen: Potential factors for its emergence and transmission. Am J Epidemiol 1976;104:170180.CrossRefGoogle ScholarPubMed
23.Gayle, WE Jr, Mayhall, CG, Lamb, VA, et al: Resistant Enterobacter cloacae in a burn center: The ineffectiveness of silver sulfadiazine. Trauma 1978;18:317323.Google Scholar
24.Smith, RF, Blasi, D, Dayton, SL, et al: Effects of sodium hypochlorite on the microbial flora of burns and normal skin. J Trauma 1974;14:938944.CrossRefGoogle ScholarPubMed
25.Haynes, BW Jr, Hench, ME: Hospital isolation system for preventing cross-contamination by staphylococcal and Pseudomonas organisms in burn wounds. Ann Surg 1965;162:641649.CrossRefGoogle ScholarPubMed
26.Burke, JF, Quinby, WC, Bondoc, CC, et al: The contribution of a bacterially isolated environment to the prevention of infection in seriously burned patients. Ann Surg 1977;186:377387.CrossRefGoogle Scholar
27.Demling, RH, Perea, A, Maly, J, et al: The use of a laminar airflow isolation system for the treatment of major burns. Am J Surg 1978;136:375378.CrossRefGoogle ScholarPubMed
28.Jarrett, F, Balish, E, Moylan, JA: The use of oral antibiotic suppression for control of infections in patients with thermal injuries. J Surg Res 1978;24:339342.CrossRefGoogle ScholarPubMed
29.Jarrett, F, Balish, E, Moylan, JA, et al: Clinical experience with prophylactic antibiotic bowel suppression in burn patients. Surgery 1978;83:523527.Google ScholarPubMed
30.Curreri, PW: Overview of recent progress in the treatment of burn wound infection. J Trauma 1981; 21(suppl):674676.CrossRefGoogle Scholar
31.Polk, RE, Mayhall, CG, Smith, J, et al: Gentamicin and tobramycin penetration into burn eschar. Pharmacokinetics and microbiological effects. Arch Surg 1983;118:295302.CrossRefGoogle ScholarPubMed
32.Hull, JH, Sarubbi, FA: Gentamicin serum concentrations: Pharmacokinetic predictions. Ann Intern Med 1976;85:183189.CrossRefGoogle ScholarPubMed